Gilead Sciences Community
Create a narrative
WA
Based on Analyst Price Targets
Navigating Challenges To Shape A Robust Future In Biotech And Healthcare Innovation
US$83.54
FV
0.08% overvalued intrinsic discount1.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 9 hours agoauthor updated this narrative